Skip to main content

Advertisement

SpringerLink
Log in

Clinical efficacy of gabexate mesilate for acute pancreatitis in children

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Children with acute pancreatitis have been treated by fasting and parenteral nutritional support, and to date, the efficacy of drugs for acute pancreatitis in children is unclear. Gabexate mesilate is a synthetic serine protease inhibitor used to prevent or treat acute pancreatitis in adult patients. The purpose of this study was to evaluate the clinical efficacy of gabexate for acute pancreatitis in children. Fifty-three children hospitalized with acute pancreatitis between 2004 and 2012 were divided between a gabexate-treated group (n = 26) and a control group without gabexate infusion (n = 27). The severity of acute pancreatitis was graded according to Balthazar scoring of computed tomography images. All subjects had a Balthazar score of <4 without pancreatic necrosis or organ failure. The median age of the patients was 11.8 years (range, 18 months–17 years). The durations of hospitalization, abdominal pain, and parenteral nutrition in the gabexate-treated group were significantly shorter than in control subjects (P = 0.032, P = 0.000, and P = 0.016, respectively). Serum levels of amylase and lipase were significantly lower in gabexate-infused children than in control subjects on day 7 (median amylase, 81 vs. 137 IU/L, P = 0.001; median lipase, 273 vs. 523 IU/L, P = 0.031). Conclusion: The present study showed that gabexate infusion has some clinical benefits for acute pancreatitis in children. The clinical application of gabexate for managing acute pancreatitis in children may be appropriate beyond conventional therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1
Fig 2

Similar content being viewed by others

Abbreviations

GM:

Gabexate mesilate

CT:

Computed tomography

References

  1. Bai Y, Gao J, Zou DW, Li ZS (2008) Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol 103:104

    Article  PubMed  Google Scholar 

  2. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH (1990) Acute pancreatitis: value of CT in establishing prognosis. Radiology 174:331–336

    PubMed  CAS  Google Scholar 

  3. Bang UC, Semb S, Nojgaard C, Bendtsen F (2008) Pharmacological approach to acute pancreatitis. World J Gastroenterol 14:2968–2976

    Article  PubMed  CAS  Google Scholar 

  4. Banks PA, Freeman ML (2006) Practice parameters committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 101:2379–2400

    Article  PubMed  Google Scholar 

  5. Benifla M, Weizman Z (2003) Acute pancreatitis in childhood: analysis of literature data. J Clin Gastroenterol 37:169–172

    Article  PubMed  Google Scholar 

  6. Bettinger JR, Grendell JH (1991) Intracellular events in the pathogenesis of acute pancreatitis. Pancreas 6(Suppl 1):S2–S6

    Article  PubMed  Google Scholar 

  7. Büchler M, Malfertheiner P, Uhl W, Schölmerich J, Stöckmann F, Adler G, Gaus W, Rolle K, Beger HG (1993) Gabexate mesilate in human acute pancreatitis. German pancreatitis study group. Gastroenterology 104:1165–1170

    PubMed  Google Scholar 

  8. Chang YJ, Chao HC, Kong MS, Hsia SH, Lai MW, Yan DC (2011) Acute pancreatitis in children. Acta Paediatr 100:740–744

    Article  PubMed  Google Scholar 

  9. Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF (2000) Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology 47:1147–1150

    PubMed  CAS  Google Scholar 

  10. Chen HM, Shyr MH, Chen MF (1997) Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis. J Formos Med Assoc 96:704–709

    PubMed  CAS  Google Scholar 

  11. DeBanto JR, Goday PS, Pedroso MR, Iftikhar R, Fazel A, Nayyar S, Conwell DL, Demeo MT, Burton FR, Whitcomb DC, Ulrich CD 2nd, Gates LK Jr (2002) Acute pancreatitis in children. Am J Gastroenterol 97:1726–1731

    Article  PubMed  Google Scholar 

  12. Kandula L, Lowe ME (2008) Etiology and outcome of acute pancreatitis in infants and toddlers. J Pediatr 152:106–110

    Article  PubMed  Google Scholar 

  13. Manes G, Uomo I, Menchise A, Rabitti PG, Ferrara EC, Uomo G (2006) Timing of antibiotic prophylaxis in acute pancreatitis: a controlled randomized study with meropenem. Am J Gastroenterol 101:1348

    Article  PubMed  CAS  Google Scholar 

  14. Morinville VD, Barmada MM, Lowe ME (2010) Increasing incidence of acute pancreatitis at an American pediatric tertiary care center: is greater awareness among physicians responsible? Pancreas 39:5–8

    Article  PubMed  Google Scholar 

  15. Pezzilli R, Zerbi A, Di Carlo V, Bassi C, Delle Fave GF, Working Group of the Italian Association for the Study of the Pancreas on Acute Pancreatitis (2010) Practical guidelines for acute pancreatitis. Pancreatology 10:523–535

    Article  PubMed  CAS  Google Scholar 

  16. Satoh H, Harada M, Tashiro S, Shiroya T, Imawaka H, Machii K (2004) The effect of continuous arterial infusion of gabexate mesilate (FOY-007) on experimental acute pancreatitis. J Med Invest 51:186–193

    Article  PubMed  Google Scholar 

  17. Seta T, Noguchi Y, Shimada T, Shikata S, Fukui T (2011) Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Gastrointest Endosc 73:700–706

    Article  PubMed  Google Scholar 

  18. Siriwardena AK, Mason JM, Balachandra S, Bagul A, Galloway S, Formela L, Hardman JG, Jamdar S (2007) Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut 56:1439–1444

    Article  PubMed  CAS  Google Scholar 

  19. Steer ML (1997) Pathogenesis of acute pancreatitis. Digestion 58(Suppl 1):46–49

    Article  PubMed  Google Scholar 

  20. Thrower E, Husain S, Gorelick F (2008) Molecular basis for pancreatitis. Curr Opin Gastroenterol 24:580–585

    Article  PubMed  Google Scholar 

  21. Van Acker GJ, Perides G, Steer ML (2006) Co-localization hypothesis: a mechanism for the intrapancreatic activation of digestive enzymes during the early phases of acute pancreatitis. World J Gastroenterol 12:1985–1990

    PubMed  Google Scholar 

  22. Wisner JR Jr, Renner IG, Grendell JH, Niederau C, Ferrell LD (1987) Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat. Pancreas 2:181–186

    Article  PubMed  CAS  Google Scholar 

  23. Working Party of the British Society of Gastroenterology, Association of Surgeons of Great Britain and Ireland, Pancreatic Society of Great Britain and Ireland, Association of Upper GI Surgeons of Great Britain and Ireland (2005) UK guidelines for the management of acute pancreatitis. Gut 54(Suppl 3):iii1–iii9

    Google Scholar 

  24. Yang F, Wang Y, Sternfeld L, Rodriguez JA, Ross C, Hayden MR, Carriere F, Liu G, Schulz I (2009) The role of free fatty acids, pancreatic lipase and Ca + signalling in injury of isolated acinar cells and pancreatitis model in lipoprotein lipase-deficient mice. Acta Physiol (Oxf) 195:13–28

    Article  PubMed  CAS  Google Scholar 

  25. Yasunaga H, Horiguchi H, Hashimoto H, Matsuda S, Fushimi K (2013) Effect and cost of treatment for acute pancreatitis with or without gabexate mesylate: a propensity score analysis using a nationwide administrative database. Pancreas 42:260–264

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Financial disclosure statement

No party having a direct interest in the results of the research or no organization with which we are associated has or will confer a benefit to us regarding this study.

Conflict of interest

There are no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Chonbuk National University Children’s Hospital, Jeonju, South Korea

    Soon Chul Kim

  2. Department of Pediatrics, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam, Gyeonggi, 463-707, South Korea

    Soon Chul Kim & Hye Ran Yang

  3. Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea

    Hye Ran Yang

Authors
  1. Soon Chul Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hye Ran Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hye Ran Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, S.C., Yang, H.R. Clinical efficacy of gabexate mesilate for acute pancreatitis in children. Eur J Pediatr 172, 1483–1490 (2013). https://doi.org/10.1007/s00431-013-2068-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-013-2068-6

Keywords

Search

Navigation